Skip to content
Get alerts
GovInfoNow
Stop using now Drug recall · FDA · Published March 23, 2024

Aruba Aloe Balm Gel Recall: Methanol Contamination Risk

Aruba Aloe Balm recalls alcohol-based gels containing methanol. These products pose chemical contamination risks. Consumers should stop using affected lots.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0459-2024DrugAruba Aloe Balm ›
Take action

Contact the company

Recalling firmAruba Aloe Balm N.V.Pitastraat 115 · Oranjestad, Aruba
✎ GovInfoNow plain-language explainer

Aruba Aloe Balm is recalling pain-relieving gels that contain methanol, a harmful chemical. Using these products could cause serious health issues due to methanol contamination. Read more at govinfonow.com/recall/32760-aruba-aloe-balm-gel-recall-methanol-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32760-aruba-aloe-balm-gel-recall-methanol-contamination-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0459-2024

Cite this page

“Aruba Aloe Balm Gel Recall: Methanol Contamination Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32760-aruba-aloe-balm-gel-recall-methanol-contamination-risk. Based on FDA recall #D-0459-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0459-2024%22&limit=1).

The FDA announced on March 23, 2024, that Aruba Aloe Balm N.V. is recalling Alcoholada Gel and Pain Relieving Gel due to chemical contamination from ethanol API containing methanol. Owners should stop using the product immediately.

How to tell if you have it

  • Aruba Aloe Balm
  • Alcoholada Gel, Pain Relieving Gel, 0.5% Lidocaine Hydrochloride
  • 8.5 fl oz (251 mL) plastic bottle UPC 0 82252 03120 9
  • 2.2 fl oz (65 mL) plastic bottle UPC 0 82252 34030 1
  • Lots: 25253, 25976, 26150, 26473, 26553, 27318, 27481, 27660, 27839, 28121, 28152, 28355, 28761, 29088, 29510, 29558, 29728, 30339, 30563 (8.5 oz); Lots: 25253, 25976, 26150, 26553, 26696, 27318, 27481, 27660, 27839, 28281, 28355, 28761, 29088, 29728, 30086, 30339, 30563 (2.2 oz)
  • Nationwide in the USA

The hazard

The product was manufactured with ethanol API that contains methanol, posing a risk of chemical contamination.

Context

GovInfoNow's records show other recent recalls include Haleon Gas-X Extra Strength Softgels (2026-06-04) and Keystone DHP Topical Anesthetic Gel (2026-05-21). Keystone Burkhart Anesthetic Gel was also recalled on 2026-05-21.

How to tell if you have this one

Check for the 8.5 fl oz (251 mL) or 2.2 fl oz (65 mL) plastic bottles with the listed lot numbers and expiration dates. The product is manufactured by Aruba Aloe Balm Inc. in Aruba.

  • Brand
    Aruba Aloe Balm
  • Product
    Alcoholada Gel, Pain Relieving Gel, 0.5% Lidocaine Hydrochloride, packaged in (a) 8.5 fl oz (251 mL) plastic bottle UPC
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class I
  • Status
    Ongoing
  • Distribution
    Nationwide in the USA
Recall numberProduct, codes & lotsQuantity
D-0459-2024Alcoholada Gel, Pain Relieving Gel, 0.5% Lidocaine Hydrochloride, packaged in (a) 8.5 fl oz (251 mL) plastic bottle UPC 0 82252 03120 9 (b) 2.2 fl oz (65 mL) plastic bottle, UPC 0 82252 34030 1 , Manufactured in Aruba by Aruba Aloe Balm Inc., Pitastraat 115, Aruba, Dutch Caribbean.; Lot, expiry: (a) 25253, Exp 5/1/2024; 25976, Exp 8/11/2024; 26150, Exp 9/11/2024; 26473, Exp 11/25/2024; 26553, Exp 12/11/2024; 27318, Exp 5/10/2025; 27481, Exp 6/15/2025; 27660, Exp 7/15/2025; 27839, Exp 8/5/2025; 28121, Exp 10/7/2025; 28152, Exp 10/18/2025; 28355, Exp 12/17/2025; 28761, Exp 2/22/2026; 29088, Exp 4/1/2026; 29510, Exp 5/11/2026; 29558, Exp 5/13/2026; 29728, Exp 6/3/2026; 30339, Exp 9/13/2026; 30563, Exp 10/27/2026. (b) 25253, Exp 5/1/2024; 25976, Exp 8/11/2024; 26150, Exp 9/11/2024; 26553, Exp 12/11/2024; 26696, Exp 1/8/2025; 27318, Exp 5/10/2025; 27481, Exp 6/15/2025; 27660, Exp 7/15/2025; 27839, Exp 8/5/2025; 28281, Exp 11/30/2025; 28355, Exp 12/17/2025; 28761, Exp 2/22/2026; 29088, Exp 4/1/2026; 29728, Exp 6/3/2026; 30086, Exp 7/26/2026; 30339, Exp 9/13/2026; 30563, Exp 10/27/2026.9,625 bottles
D-0460-2024Aruba Aloe Hand Sanitizer Gel, 80% Alcohol, 12 fl oz (355 mL) plastic bottle, Manufactured in Aruba by Aruba Aloe Balm Inc., Pitastraat 115, Aruba, Dutch Caribbean. UPC 0 82252 03300 5; Lot #: 25160, Exp 4/16/2024; 25344, Exp 5/20/2024, 25580, Exp 6/15/2024; 25828, Exp 7/28/2024; 26057, Exp 8/25/2024; 26195, Exp 9/18/2024; 26471, Exp 11/25/2024; 26754, Exp 1/20/2025; 26821, Exp 2/2/2025; 27005, Exp 3/11/2025; 27518, Exp 6/22/2025; 27927, Exp 8/26/2025; 28176, Exp 10/22/2025; 28392, Exp 12/31/2025.5299 bottles
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the recalled gel products as they contain methanol which can cause serious health issues.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 39 days after the firm started it.

1. Firm started the recall: Mar 23, 202412. FDA classified it Class I: Apr 23, 202423. Published in FDA’s Enforcement Report: May 1, 202432024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Which lot numbers are affected?

Affected lot numbers include 25253, 25976, 26150, 26473, 26553, 27318, 27481, 27660, 27839, 28121, 28152, 28355, 28761, 29088, 29510, 29558, 29728, 30339, and 30563 for both bottle sizes.

Similar recalls

Medically Minded Hand Sanitizer Gel Recall: Low Ethanol Content and Methanol Risk
Medically MindedAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INC

Latest drug recalls

Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0459-2024 (March 23, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0459-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA